Marco Lanza

681 total citations
30 papers, 569 citations indexed

About

Marco Lanza is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Marco Lanza has authored 30 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Marco Lanza's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Marco Lanza is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Marco Lanza collaborates with scholars based in Italy, Germany and India. Marco Lanza's co-authors include Gianfranco Caselli, Maurizio Raiteri, Giambattista Bonanno, Lucio C. Rovati, Laura Mennuni, Francesco Makovec, Mario Pende, Anita Gemignani, Anna Fassio and Riccardo Chiusaroli and has published in prestigious journals such as Cancer Research, Chemical Communications and Brain Research.

In The Last Decade

Marco Lanza

30 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Lanza Italy 15 247 225 116 115 115 30 569
Sílvia Sánchez Spain 18 126 0.5× 227 1.0× 47 0.4× 55 0.5× 106 0.9× 53 638
Shouxi Xu United States 17 194 0.8× 297 1.3× 28 0.2× 124 1.1× 115 1.0× 31 807
C. Nathaniel Roybal United States 12 130 0.5× 439 2.0× 91 0.8× 38 0.3× 52 0.5× 20 973
Yuwan Lin China 13 70 0.3× 132 0.6× 48 0.4× 57 0.5× 114 1.0× 37 469
Kaoru Nakao Japan 14 317 1.3× 286 1.3× 79 0.7× 25 0.2× 117 1.0× 37 613
Silvia Pasquini Italy 16 93 0.4× 314 1.4× 24 0.2× 93 0.8× 129 1.1× 43 826
Brock Brown United States 12 83 0.3× 254 1.1× 42 0.4× 34 0.3× 109 0.9× 19 720
Sisi Peng China 9 98 0.4× 218 1.0× 57 0.5× 29 0.3× 48 0.4× 17 525
Claudia Jomphe Canada 9 234 0.9× 228 1.0× 53 0.5× 36 0.3× 84 0.7× 17 498
João M. Bráz United States 14 227 0.9× 243 1.1× 33 0.3× 54 0.5× 278 2.4× 19 670

Countries citing papers authored by Marco Lanza

Since Specialization
Citations

This map shows the geographic impact of Marco Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Lanza more than expected).

Fields of papers citing papers by Marco Lanza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Lanza. The network helps show where Marco Lanza may publish in the future.

Co-authorship network of co-authors of Marco Lanza

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Lanza. A scholar is included among the top collaborators of Marco Lanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Lanza. Marco Lanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Caselli, Gianfranco, Albino Bonazzi, Marco Lanza, et al.. (2018). Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug. Arthritis Research & Therapy. 20(1). 39–39. 32 indexed citations
3.
Lanza, Marco, et al.. (2017). Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis. Journal of Pain Research. Volume 10. 1033–1043. 15 indexed citations
4.
Caprioli, Giovanni, Massimo Ricciutelli, Gianni Sagratini, et al.. (2015). Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation. European Journal of Pharmacology. 769. 219–224. 2 indexed citations
5.
Caselli, Gianfranco, et al.. (2015). Analgesic efficacy of cr4056, a novel i2-imidazoline receptor ligand, in the rat monosodium iodoacetate model of osteoarthritic pain. Osteoarthritis and Cartilage. 23. A358–A358. 2 indexed citations
6.
Paolino, Marco, Laura Mennuni, Germano Giuliani, et al.. (2014). Dendrimeric tetravalent ligands for the serotonin-gated ion channel. Chemical Communications. 50(62). 8582–8582. 18 indexed citations
7.
Lanza, Marco, et al.. (2014). Modulation of imidazolineI2binding sites byCR4056 relieves postoperative hyperalgesia in male and female rats. British Journal of Pharmacology. 171(15). 3693–3701. 28 indexed citations
8.
Chiusaroli, Riccardo, Marcella Visentini, Laura Mennuni, et al.. (2013). Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis. Osteoarthritis and Cartilage. 21(11). 1807–1810. 50 indexed citations
9.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2013). Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds. European Journal of Medicinal Chemistry. 63. 85–94. 28 indexed citations
10.
Bello, Fabio Del, Eleonora Diamanti, Mario Giannella, et al.. (2013). Exploring Multitarget Interactions to Reduce Opiate Withdrawal Syndrome and Psychiatric Comorbidity. ACS Medicinal Chemistry Letters. 4(9). 875–879. 9 indexed citations
11.
Lanza, Marco, et al.. (2011). Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. Journal of Pain Research. 4. 111–111. 43 indexed citations
12.
Chiusaroli, Riccardo, Paolo Garofalo, Stefano Espinoza, et al.. (2010). Antipsychotic-like effects of the N-methyl-d-aspartate receptor modulator neboglamine: An immunohistochemical and behavioural study in the rat. Pharmacological Research. 61(5). 430–436. 8 indexed citations
13.
Mennuni, Laura, et al.. (2009). Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression. Osteoarthritis and Cartilage. 17(8). 1076–1083. 49 indexed citations
14.
Sarre, Sophie, et al.. (2008). In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats. European Journal of Pharmacology. 584(2-3). 297–305. 13 indexed citations
15.
Losi, Gabriele, et al.. (2005). Functional in vitro characterization of CR 3394: A novel voltage dependent N-methyl-d-aspartate (NMDA) receptor antagonist. Neuropharmacology. 50(3). 277–285. 12 indexed citations
16.
Lanza, Marco & Francesco Makovec. (2000). Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCKB receptors located on glutamatergic interneurons. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(1). 33–38. 16 indexed citations
17.
18.
Lanza, Marco & Francesco Makovec. (1997). Cognition Enhancing Profile of CR 2249, a New NMDA‐Glycine Site Modulator. CNS Drug Reviews. 3(3). 245–259. 1 indexed citations
19.
Pende, Mario, Marco Lanza, Giambattista Bonanno, & Maurizio Raiteri. (1993). Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a γ-aminobutyric acidB (GABAB) receptor subtype. Brain Research. 604(1-2). 325–330. 48 indexed citations
20.
Lanza, Marco, Anna Fassio, Anita Gemignani, Giambattista Bonanno, & Maurizio Raiteri. (1993). CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. European Journal of Pharmacology. 237(2-3). 191–195. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvia Sánchez Breakdown of academic impact, for papers by Shouxi Xu Breakdown of academic impact, for papers by C. Nathaniel Roybal Breakdown of academic impact, for papers by Yuwan Lin Breakdown of academic impact, for papers by Kaoru Nakao Breakdown of academic impact, for papers by Silvia Pasquini Breakdown of academic impact, for papers by Brock Brown Breakdown of academic impact, for papers by Sisi Peng Breakdown of academic impact, for papers by Claudia Jomphe Breakdown of academic impact, for papers by João M. Bráz
Rankless by CCL
2026